Huawei pours 25% of revenue into R&D as H1 profit drops 36%
Synopsis
Huawei spent a record 121.4 billion yuan — over 25% of its H1 2026 revenue — on R&D, sending net profit down 36% and flipping operating cash flow to negative 39.9 billion yuan. The aggressive bet on Ascend AI chips and Kirin processors signals a deliberate pivot toward technological self-sufficiency over profitability.
Key Takeaways
Huawei spent 121.4 billion yuan (US$18 billion) on R&D in the first half of 2026 , up 25 per cent year on year and exceeding 25 per cent of total revenue.
Net profit fell 36 per cent to 23.8 billion yuan from 37.2 billion yuan in the same period last year, marking a second consecutive year of first-half profit decline.
Net operating cash flow swung to negative 39.9 billion yuan from a positive 31.2 billion yuan a year earlier.
Revenue grew 9.55 per cent to 467.8 billion yuan , supported by Mate handset shipments and rising demand for Ascend AI chips .
Figures were disclosed via a bond filing with the Shanghai Clearing House , as Huawei remains a privately held company.
Huawei Technologies allocated more than a quarter of its first-half revenue to research and development in the six months through June 2026, as the Shenzhen-based company doubled down on technological self-reliance at the cost of near-term profitability. Net profit fell 36 per cent year on year, underscoring the scale of the company's strategic bet on homegrown innovation.
R&D Surge Drives Record Spending
R&D expenses climbed 25 per cent year on year to 121.4 billion yuan (US$18 billion) for the first half of 2026, representing over 25 per cent of total revenue, according to a filing with the Shanghai Clearing House, China's primary interbank clearing counterparty. The spike in technology investment, combined with rising component costs, compressed net profit to 23.8 billion yuan from 37.2 billion yuan in the same period a year earlier.
This marks the second consecutive year of declining first-half profits for Huawei, reinforcing the view that the company is deliberately trading short-term earnings for long-term technological independence.
Cash Flow Swings Sharply Negative
The financial strain extended beyond the income statement. Net operating cash flow swung to a negative 39.9 billion yuan from a positive inflow of 31.2 billion yuan in the same period last year — a dramatic reversal that signals intensifying capital demands. The deterioration reflects both the front-loaded nature of semiconductor and AI infrastructure investment and the elevated cost of sourcing advanced components under ongoing trade restrictions.
Revenue Growth Holds Steady on Smartphones and AI Chips
Despite the profit squeeze, top-line growth remained resilient. Revenue rose 9.55 per cent to 467.8 billion yuan from 427 billion yuan a year earlier, driven by a strong rebound in smartphone shipments — anchored by Mate handsets powered by the in-house Kirin processor — and accelerating demand for its Ascend AI chips. The latter has emerged as a critical alternative for Chinese enterprises unable to access Nvidia hardware under US export controls.
As a privately held entity, Huawei releases operational figures only occasionally, primarily through bond issuance disclosures on the Shanghai Clearing House platform.
Why It Matters
The numbers crystallise Huawei's strategic posture: sacrifice near-term margins to build sovereign capability across semiconductors, AI, and mobile ecosystems. With rivals such as Oppo and the spun-off Honor competing aggressively in handsets, and domestic AI model developers like DeepSeek and iFlyTek expanding their compute needs, Huawei's Ascend chip business sits at the intersection of multiple high-growth demand vectors.
What's Next
Investors and industry analysts will be watching whether the cash flow deficit stabilises in the second half, and whether Ascend AI chip revenue can scale fast enough to offset the sustained R&D drag. Any acceleration in domestic AI infrastructure spending — particularly from state-backed cloud operators — would directly benefit Huawei's most strategically important product line.
Point of View
But Ascend chip order backlog, which will indicate whether domestic AI demand can eventually absorb the R&D burden.
NationPress
31 Aug 2026
Frequently Asked Questions
How much did Huawei spend on R&D in the first half of 2026?
Huawei spent 121.4 billion yuan (US$18 billion) on research and development in the first six months of 2026 , a 25 per cent increase year on year. This represented more than 25 per cent of the company's total first-half revenue, according to a filing with the Shanghai Clearing House .
Why did Huawei's profit fall in H1 2026?
Huawei 's net profit fell 36 per cent to 23.8 billion yuan primarily because of surging R&D expenditure and rising component costs. The company is prioritising long-term technological self-reliance — particularly in semiconductors and AI — over near-term earnings.
What drove Huawei's revenue growth despite the profit decline?
Huawei 's revenue rose 9.55 per cent to 467.8 billion yuan , supported by a rebound in smartphone shipments led by Mate handsets with the in-house Kirin processor , and accelerating demand for its Ascend AI chips . The AI chip segment has become a key alternative for Chinese enterprises restricted from purchasing Nvidia hardware.
What happened to Huawei's cash flow in the first half of 2026?
Huawei 's net operating cash flow swung to negative 39.9 billion yuan from a positive inflow of 31.2 billion yuan in the same period last year. The reversal reflects the capital-intensive demands of building out semiconductor and AI infrastructure capabilities.
How does Huawei's R&D strategy compare to global tech rivals?
Spending over 25 per cent of revenue on R&D places Huawei among the most aggressive technology investors globally, well above the industry norm for hardware-focused companies. The strategy mirrors the approach of firms under supply-chain pressure — prioritising in-house capability in chips like the Kirin and Ascend lines rather than relying on external suppliers subject to geopolitical risk.
